Yasmin Akhunji
Endocrinology, Diabetes & Metabolism · Phoenix, AZNPI 1790918738
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,514 of the $5,385 with a category attached, or 83.8%. It is spread thinly across 32 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,930 and has fallen 73.0% since, to $522 in 2023.
Across 310 payments — averaging $17.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tandem Diabetes Care, Inc.$850
- Novo Nordisk$646
- Lilly USA, LLC$588
- Insulet Corporation$487
- AstraZeneca$324
- Mannkind Corporation$297
- plus $2K from 26 others
What the payments were for
- Speaking & faculty fees$80015%
- Food & beverage$4,51484%
- Education$120%
- Gifts$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tandem Diabetes Care, Inc. | 7 | $850 |
| Novo Nordisk | 68 | $646 |
| Lilly USA, LLC | 41 | $588 |
| Insulet Corporation | 31 | $487 |
| AstraZeneca(2 entities) | 18 | $324 |
| Mannkind Corporation | 14 | $297 |
| Abbott | 16 | $247 |
| Sanofi-aventis U.S. LLC | 18 | $239 |
| Dexcom, Inc. | 11 | $186 |
| AbbVie | 9 | $176 |
| Embecta Corp. | 7 | $173 |
| Corcept Therapeutics | 11 | $157 |
| Xeris Pharmaceuticals, Inc. | 7 | $122 |
| Amneal Pharmaceuticals LLC | 7 | $121 |
| Medtronic(2 entities) | 7 | $117 |
| Zealand Pharma US, Inc. | 5 | $101 |
| Boehringer Ingelheim | 5 | $86 |
| Amgen(2 entities) | 4 | $70 |
| Radius Health, Inc. | 3 | $66 |
| Clarus Therapeutics Inc. | 3 | $57 |
| Merck | 4 | $51 |
| BD | 2 | $44 |
| Ascensia Diabetes Care US Inc. | 2 | $31 |
| Intuity Medical Inc | 2 | $27 |
| Lifescan, Inc. | 1 | $19 |
| Alfasigma USA, Inc. | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $15 |
| Medicure Pharma Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Acerus Pharmaceuticals Corporation | 1 | $14 |
| Bayer | 1 | $14 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- t:slim X2 insulin pump$550
- t-slim insulin pump$250
- Omnipod$115
How this compares
$5,385 in reported general payments places this provider in the 65th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.
See all endocrinology, diabetes & metabolism providers in Arizona →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Liothyronine Sodium | 15 | $1,301 |
| Levothyroxine Sodium | 34 | $381 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $121 | $38134 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.
Other endocrinology, diabetes & metabolism in Phoenix
- Kevin YuenPhoenix$404K
- Joan BaileyPhoenix$316K
- Anna BoronPhoenix$32K
- Kari EdlingPhoenix$23K
- James DeerPhoenix$13K
- Lory BarazPhoenix$10K
- Sathya JyothinagaramPhoenix$10K
- Philip LevyPhoenix$9K
- Richard ArakakiPhoenix$6K
- Ahmad Al MaradniPhoenix$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.